Dailypharm Live Search Close

Sales of erectile dysfunction generic drugs are increasing

By An, Kyung-Jin | translator Choi HeeYoung

21.03.05 12:20:54

°¡³ª´Ù¶ó 0
Last year's erectile dysfunction treatment market sales reached ₩112.4 billion, ¡é1.3% from the previous year

Due to COVID-19 pandemic, suffer heavily in the first half of last year

PalPal continues to be number one. Leading sales of generic such as Cendom and Gugu

Sales of the domestic erectile dysfunction treatment market decreased due to COVID-19. Sales declined, mainly for large items in the early days of the COVID-19 spread, and recovered after the second half of the year. Although sales of major products were low, generic products sold by Korean companies such as Hanmi and Chong Kun Dang were launched.

According to IQVIA, a drug research institute on the 5th, the domestic erectile dysfunction treatment market last year was ₩11.2 billion, a 1.3% decrease from the previous year.



After the expiration of patents for blockbuster drugs such as Viagra and Cialis, generics were released, increasing sales in the erectile dysfunction treat

An, Kyung-Jin(kjan@dailypharm.com)
If you want to see the full article, please JOIN US (click)